The WACC of BiVictriX Therapeutics PLC (BVX.L) is 12.6%.
| Range | Selected | |
| Cost of equity | 11.40% - 14.40% | 12.90% |
| Tax rate | 15.30% - 15.60% | 15.45% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 11.2% - 14.1% | 12.6% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 1.24 | 1.35 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 11.40% | 14.40% |
| Tax rate | 15.30% | 15.60% |
| Debt/Equity ratio | 0.03 | 0.03 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 11.2% | 14.1% |
| Selected WACC | 12.6% | |